• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用CT密度测定法检测α1-抗胰蛋白酶缺乏症中肺气肿的进展;方法学进展

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances.

作者信息

Parr David G, Sevenoaks Martin, Deng Chunqin, Stoel Berend C, Stockley Robert A

机构信息

Department of Respiratory Medicine, University Hospitals of Coventry and Warwickshire, Clifford Bridge Road, Coventry, CV2 2DX, UK.

出版信息

Respir Res. 2008 Feb 13;9(1):21. doi: 10.1186/1465-9921-9-21.

DOI:10.1186/1465-9921-9-21
PMID:18271964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2287169/
Abstract

BACKGROUND

Computer tomography (CT) densitometry is a potential tool for detecting the progression of emphysema but the optimum methodology is uncertain. The level of inspiration affects reproducibility but the ability to adjust for this variable is facilitated by whole lung scanning methods. However, emphysema is frequently localised to sub-regions of the lung and targeted densitometric sampling may be more informative than whole lung assessment.

METHODS

Emphysema progression over a 2-year interval was assessed in 71 patients (alpha 1-antitrypsin deficiency with PiZ phenotype) with CT densitometry, using the 15th percentile point (Perc15) and voxel index (VI) -950 Hounsfield Units (HU) and -910 HU (VI -950 and -910) on whole lung, limited single slices, and apical, central and basal thirds. The relationship between whole lung densitometric progression (DeltaCT) and change in CT-derived lung volume (DeltaCTVol) was characterised, and adjustment for lung volume using statistical modelling was evaluated.

RESULTS

CT densitometric progression was statistically significant for all methods. DeltaCT correlated with DeltaCTVol and linear regression indicated that nearly one half of lung density loss was secondary to apparent hyperinflation. The most accurate measure was obtained using a random coefficient model to adjust for lung volume and the greatest progression was detected by targeted sampling of the middle third of the lung.

CONCLUSION

Progressive hyperinflation may contribute significantly to loss of lung density, but volume effects and absolute tissue loss can be identified by statistical modelling. Targeted sampling of the middle lung region using Perc15 appears to be the most robust measure of emphysema progression.

摘要

背景

计算机断层扫描(CT)密度测定法是检测肺气肿进展的一种潜在工具,但最佳方法尚不确定。吸气水平会影响可重复性,但全肺扫描方法有助于对该变量进行调整。然而,肺气肿常局限于肺的亚区域,靶向密度测定采样可能比全肺评估更具信息量。

方法

对71例(PiZ表型的α1抗胰蛋白酶缺乏症)患者进行CT密度测定,评估其在2年期间肺气肿的进展情况,使用全肺、有限单层面以及肺尖、肺中和肺底三分之一区域的第15百分位数(Perc15)和体素指数(VI)-950亨氏单位(HU)及-910 HU(VI -950和-910)。对全肺密度测定进展(DeltaCT)与CT衍生肺容积变化(DeltaCTVol)之间的关系进行了表征,并评估了使用统计模型对肺容积进行调整的情况。

结果

所有方法的CT密度测定进展均具有统计学意义。DeltaCT与DeltaCTVol相关,线性回归表明近一半的肺密度损失继发于明显的肺过度充气。使用随机系数模型调整肺容积可获得最准确的测量结果,通过对肺中三分之一区域进行靶向采样检测到的进展最大。

结论

进行性肺过度充气可能对肺密度损失有显著影响,但通过统计模型可识别容积效应和绝对组织损失。使用Perc15对肺中部区域进行靶向采样似乎是评估肺气肿进展最可靠的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/0170ff2a0c6a/1465-9921-9-21-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/1af122e00506/1465-9921-9-21-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/c7c6b942c1e9/1465-9921-9-21-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/071e4a3f19d4/1465-9921-9-21-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/0170ff2a0c6a/1465-9921-9-21-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/1af122e00506/1465-9921-9-21-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/c7c6b942c1e9/1465-9921-9-21-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/071e4a3f19d4/1465-9921-9-21-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a9/2287169/0170ff2a0c6a/1465-9921-9-21-4.jpg

相似文献

1
Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances.使用CT密度测定法检测α1-抗胰蛋白酶缺乏症中肺气肿的进展;方法学进展
Respir Res. 2008 Feb 13;9(1):21. doi: 10.1186/1465-9921-9-21.
2
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.在一项关于α1抗胰蛋白酶缺乏症增强疗法的随机安慰剂对照研究中探索CT密度测定法的最佳使用方法。
Respir Res. 2009 Aug 13;10(1):75. doi: 10.1186/1465-9921-10-75.
3
Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.通过年度CT评估严重α1-抗胰蛋白酶缺乏症患者肺气肿的进展情况。
Acta Radiol. 1997 Sep;38(5):826-32. doi: 10.1080/02841859709172418.
4
Influence of calibration on densitometric studies of emphysema progression using computed tomography.校准对使用计算机断层扫描进行的肺气肿进展密度测定研究的影响。
Am J Respir Crit Care Med. 2004 Oct 15;170(8):883-90. doi: 10.1164/rccm.200403-326OC. Epub 2004 Jul 21.
5
Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.计算机断层扫描肺密度测定法用于监测α1抗胰蛋白酶缺乏症患者肺气肿的验证
Thorax. 2006 Jun;61(6):485-90. doi: 10.1136/thx.2005.054890. Epub 2006 Mar 14.
6
SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.斯巴达临床试验设计:探索两种剂量方案的α1-蛋白酶抑制剂增强疗法在α1-抗胰蛋白酶缺乏症中的疗效和安全性。
Respir Med. 2015 Apr;109(4):490-9. doi: 10.1016/j.rmed.2015.01.022. Epub 2015 Feb 13.
7
Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.37至39岁α-1抗胰蛋白酶缺乏个体的肺功能与CT肺密度测定
Int J Chron Obstruct Pulmon Dis. 2018 Nov 8;13:3689-3698. doi: 10.2147/COPD.S167497. eCollection 2018.
8
Volume adjustment of lung density by computed tomography scans in patients with emphysema.通过计算机断层扫描对肺气肿患者的肺密度进行容积调整。
Acta Radiol. 2004 Jul;45(4):417-23. doi: 10.1080/02841850410005525.
9
Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症患者健康状况的年度变化与计算机断层扫描得出的肺密度之间的相关性。
Thorax. 2003 Dec;58(12):1027-30. doi: 10.1136/thorax.58.12.1027.
10
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.35岁α-1抗胰蛋白酶缺乏症患者与健康对照者的肺功能和CT密度测定
COPD. 2015 Apr;12(2):162-7. doi: 10.3109/15412555.2014.922068. Epub 2014 Oct 3.

引用本文的文献

1
Emphysema progression risk in COPD using a localized foundational model of density evolution.使用密度演变的局部基础模型评估慢性阻塞性肺疾病(COPD)中肺气肿进展风险
NPJ Digit Med. 2025 Aug 28;8(1):556. doi: 10.1038/s41746-025-01917-3.
2
The Use of CT Densitometry for the Assessment of Emphysema in Clinical Trials: A Position Paper from the Fleischner Society.CT密度测定法在临床试验中用于评估肺气肿:来自弗莱施纳学会的立场文件。
Am J Respir Crit Care Med. 2025 Mar 24;211(5):709-28. doi: 10.1164/rccm.202410-2012SO.
3
Novel Lobe-based Transformer model (LobTe) to predict emphysema progression in Alpha-1 Antitrypsin Deficiency.

本文引用的文献

1
Lung volumes and forced ventilatory flows.肺容积与用力通气流量
Eur Respir J. 1993 Mar;6 Suppl 16:5-40. doi: 10.1183/09041950.005s1693.
2
Predictors of mortality in patients with emphysema and severe airflow obstruction.肺气肿和严重气流阻塞患者的死亡率预测因素。
Am J Respir Crit Care Med. 2006 Jun 15;173(12):1326-34. doi: 10.1164/rccm.200510-1677OC. Epub 2006 Mar 16.
3
Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.计算机断层扫描肺密度测定法用于监测α1抗胰蛋白酶缺乏症患者肺气肿的验证
用于预测α-1抗胰蛋白酶缺乏症中肺气肿进展的新型基于肺叶的Transformer模型(LobTe)。
Comput Biol Med. 2025 Feb;185:109500. doi: 10.1016/j.compbiomed.2024.109500. Epub 2024 Dec 6.
4
Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies.多基因和转录风险评分在慢性阻塞性肺疾病基因(COPDGene)和慢性阻塞性肺疾病纵向调查评估预测研究(ECLIPSE)队列研究中识别慢性阻塞性肺疾病亚型。
EBioMedicine. 2024 Dec;110:105429. doi: 10.1016/j.ebiom.2024.105429. Epub 2024 Nov 6.
5
Occupational Exposures, Chronic Obstructive Pulmonary Disease and Tomographic Findings in the Spanish Population.西班牙人群中的职业暴露、慢性阻塞性肺疾病与断层扫描结果
Toxics. 2024 Sep 24;12(10):689. doi: 10.3390/toxics12100689.
6
Lung Transcriptomics Links Emphysema to Barrier Dysfunction and Macrophage Subpopulations.肺转录组学将肺气肿与屏障功能障碍及巨噬细胞亚群联系起来。
Am J Respir Crit Care Med. 2024 Jun 27;211(1):75-90. doi: 10.1164/rccm.202305-0793OC.
7
Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema.基于血液的肺气肿转录组学和蛋白质组学生物标志物。
Am J Respir Crit Care Med. 2024 Feb 1;209(3):273-287. doi: 10.1164/rccm.202301-0067OC.
8
Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers.基于聚类的 COPD 亚型具有不同的纵向结局和多组学生物标志物。
BMJ Open Respir Res. 2022 Aug;9(1). doi: 10.1136/bmjresp-2021-001182.
9
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort.在SPIROMICS队列中,25%-75%用力呼气流量将慢性阻塞性肺疾病的生理学与肺气肿及疾病严重程度联系起来。
Chronic Obstr Pulm Dis. 2022 Apr 29;9(2):111-121. doi: 10.15326/jcopdf.2021.0241.
10
Pulmonary Emphysema Regional Distribution and Extent Assessed by Chest Computed Tomography Is Associated With Pulmonary Function Impairment in Patients With COPD.通过胸部计算机断层扫描评估的肺气肿区域分布和范围与慢性阻塞性肺疾病患者的肺功能损害相关。
Front Med (Lausanne). 2021 Sep 23;8:705184. doi: 10.3389/fmed.2021.705184. eCollection 2021.
Thorax. 2006 Jun;61(6):485-90. doi: 10.1136/thx.2005.054890. Epub 2006 Mar 14.
4
Variability in densitometric assessment of pulmonary emphysema with computed tomography.计算机断层扫描对肺气肿进行密度测定评估时的变异性。
Invest Radiol. 2005 Dec;40(12):777-83. doi: 10.1097/01.rli.0000186418.31139.21.
5
Volume adjustment of lung density by computed tomography scans in patients with emphysema.通过计算机断层扫描对肺气肿患者的肺密度进行容积调整。
Acta Radiol. 2004 Jul;45(4):417-23. doi: 10.1080/02841850410005525.
6
Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment.α1抗胰蛋白酶缺乏症中肺气肿的分布模式影响肺功能损害。
Am J Respir Crit Care Med. 2004 Dec 1;170(11):1172-8. doi: 10.1164/rccm.200406-761OC. Epub 2004 Aug 11.
7
Influence of calibration on densitometric studies of emphysema progression using computed tomography.校准对使用计算机断层扫描进行的肺气肿进展密度测定研究的影响。
Am J Respir Crit Care Med. 2004 Oct 15;170(8):883-90. doi: 10.1164/rccm.200403-326OC. Epub 2004 Jul 21.
8
Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema.研讨会报告:肺气肿纵向研究中的定量计算机断层扫描
Eur Respir J. 2004 May;23(5):769-75. doi: 10.1183/09031936.04.00026504.
9
Predictors of mortality in alpha1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症患者死亡率的预测因素
Thorax. 2003 Dec;58(12):1020-6. doi: 10.1136/thorax.58.12.1020.
10
Comparison of spirometric-gated and -ungated HRCT in COPD.慢性阻塞性肺疾病(COPD)中肺量计门控和非门控高分辨率计算机断层扫描(HRCT)的比较
J Comput Assist Tomogr. 2003 May-Jun;27(3):375-9. doi: 10.1097/00004728-200305000-00013.